Engineering Technician III (Internal Medicine-Nephrology - Galveston) jobs in United States
cer-icon
Apply on Employer Site
company-logo

The University of Texas Medical Branch · 3 days ago

Engineering Technician III (Internal Medicine-Nephrology - Galveston)

The University of Texas Medical Branch (UTMB) is seeking a microscope technologist to develop and test a microscopic imaging-based renal disease diagnostic platform. The role involves operating and maintaining super-resolution microscopes and collaborating with a team of physicians and scientists to establish innovative diagnostic tools for kidney disease patients.

Hospital & Health Care
check
Comp. & Benefits
check
H1B Sponsor Likelynote

Responsibilities

Report directly to the director of the Center, work closely with other team members
Operate and maintain a state-of-the-art super-resolution microscope (N-SIM) daily
Acquire fluorescence-based images from processed tissues through N-SIM
Process the fluorescence images following semi-automated programs
Document, store, backup acquired and processed images
Order essential lab materials/office supply

Qualification

Fluorescence microscopySuper-resolution microscopyBiological sciencesMedical sciencesTeam collaboration

Required

BS degree in Biological, Medical Sciences or any directly related field
Two (2) years of experience operating fluorescence-based microscopes

Company

The University of Texas Medical Branch

company-logo
The University of Texas Medical Branch is a component of the University of Texas System located in Galveston, Texas

H1B Sponsorship

The University of Texas Medical Branch has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (73)
2024 (66)
2023 (52)
2022 (57)
2021 (49)
2020 (50)

Funding

Current Stage
Late Stage
Total Funding
$35M
Key Investors
National Institute of Allergy and Infectious Diseases
2024-09-13Grant
2019-04-09Grant· $35M

Leadership Team

leader-logo
Donna Sollenberger
EVP and CEO, Health System
linkedin
Company data provided by crunchbase